title: Globin chain synthesis in myelodysplastic syndromes.
abstract: Globin chain synthesis was studied in the reticulocytes of 30 patients with various myelodysplastic syndromes (MDS) to determine the alpha:beta globin chain synthetic ratio and its probable prognostic value. The mean (SD) value of the total alpha:beta ratio was 0.82 (0.45) ranging from 0.05 to 1.73. The same ratio in 10 normal controls was 1.01 (0.04). This difference was significant. Furthermore, the alpha:beta ratios were lower than normal in 14 patients (alpha-thalassaemia-like) (group I), almost within normal limits in 11 (group II), and higher than normal in five (beta-thalassaemia-like) (group III). In each group almost all the FAB subtypes were represented. The addition of exogenous haem in several of the test samples resulted in a slight to pronounced increase in the alpha:beta ratios, particularly in group I. In 92% of the high risk cases (refractory anaemia with excess blasts (RAEB), chronic myelomonocytic leukaemia (CMML] or 87.5% of patients who finally developed acute non-lyphoid leukaemia (ANLL) low or normal alpha:beta ratios were found. No significant correlation was noticed between alpha:beta ratios and various haematological variables or survival. It is concluded that in MDS the alpha:beta ratio varied enormously across the entire population of patients, as well as within each FAB subtype, thereby restricting its prognostic value. Although haem deficiency may be implicated in some cases of MDS, why this should be remains unclear.
authors.affiliation: Second Department of Internal Medicine, University of Athens, Greece.
authors.forename: G
authors.initials: G
authors.lastname: Chalevelakis
authors.forename: S
authors.initials: S
authors.lastname: Karaoulis
authors.forename: A G
authors.initials: AG
authors.lastname: Yalouris
authors.forename: T
authors.initials: T
authors.lastname: Economopoulos
authors.forename: N
authors.initials: N
authors.lastname: Tountas
authors.forename: S
authors.initials: S
authors.lastname: Raptis
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005500:Follow-Up Studies; D005914:Globins / Q000096:biosynthesis* / Q000187:drug effects; D006427:Hemin / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000097:blood* / Q000401:mortality; D011379:Prognosis; D012156:Reticulocytes / Q000378:metabolism*; D012588:Scintillation Counting; D015996:Survival Rate
chemical_list: D006427:Hemin; D005914:Globins